%0 Journal Article
%T SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).
%A Morán LO
%A Mateo FJP
%A Balanyà RP
%A Revuelta JR
%A Martínez SR
%A Fombella JPB
%A Vázquez EMB
%A Caro NL
%A Langa JM
%A Fernández MS
%J Clin Transl Oncol
%V 0
%N 0
%D 2024 Aug 7
%M 39110395
%F 3.34
%R 10.1007/s12094-024-03605-2
%X The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this new update to the guidelines, SEOM seeks to incorporate recent evidence, based on a critical review of the literature, to provide practical current recommendations for the prophylactic and therapeutic management of VTE in patients with cancer. Special clinical situations whose management and/or choice of currently recommended therapeutic options (low-molecular-weight heparins [LMWHs] or direct-acting oral anticoagulants [DOACs]) is controversial are included.